Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebellar Neoplasms | 10 | 2024 | 478 | 3.360 |
Why?
|
| Medulloblastoma | 11 | 2024 | 572 | 2.870 |
Why?
|
| Intracranial Aneurysm | 5 | 2023 | 128 | 2.570 |
Why?
|
| Subarachnoid Hemorrhage | 4 | 2023 | 101 | 2.410 |
Why?
|
| Brain Abscess | 5 | 2024 | 75 | 2.210 |
Why?
|
| Spinal Puncture | 2 | 2021 | 62 | 1.460 |
Why?
|
| Neurosurgery | 6 | 2022 | 117 | 1.450 |
Why?
|
| Infratentorial Neoplasms | 3 | 2024 | 48 | 1.450 |
Why?
|
| Pituitary Neoplasms | 3 | 2021 | 216 | 1.280 |
Why?
|
| Canada | 12 | 2024 | 440 | 1.260 |
Why?
|
| Neurosurgical Procedures | 6 | 2024 | 632 | 1.190 |
Why?
|
| Empyema, Subdural | 2 | 2023 | 10 | 1.120 |
Why?
|
| Embolization, Therapeutic | 2 | 2023 | 605 | 1.100 |
Why?
|
| Mutism | 2 | 2024 | 31 | 1.040 |
Why?
|
| Endovascular Procedures | 3 | 2021 | 472 | 0.990 |
Why?
|
| Axis, Cervical Vertebra | 1 | 2023 | 6 | 0.920 |
Why?
|
| Odontoid Process | 1 | 2023 | 13 | 0.920 |
Why?
|
| Encephalocele | 1 | 2024 | 59 | 0.910 |
Why?
|
| Atlanto-Axial Joint | 1 | 2023 | 26 | 0.900 |
Why?
|
| Epidural Abscess | 1 | 2023 | 13 | 0.890 |
Why?
|
| Laminectomy | 1 | 2023 | 50 | 0.880 |
Why?
|
| Joint Instability | 1 | 2023 | 78 | 0.860 |
Why?
|
| Spinal Cord Diseases | 1 | 2023 | 88 | 0.860 |
Why?
|
| Paranasal Sinuses | 1 | 2023 | 64 | 0.850 |
Why?
|
| Cerebral Palsy | 1 | 2023 | 84 | 0.810 |
Why?
|
| Astrocytoma | 2 | 2024 | 326 | 0.800 |
Why?
|
| Sinusitis | 1 | 2023 | 148 | 0.790 |
Why?
|
| Dystonia | 1 | 2023 | 172 | 0.780 |
Why?
|
| Aneurysm, False | 1 | 2023 | 142 | 0.770 |
Why?
|
| Tarlov Cysts | 1 | 2021 | 1 | 0.770 |
Why?
|
| Oculomotor Nerve Diseases | 1 | 2021 | 22 | 0.760 |
Why?
|
| Smartphone | 2 | 2019 | 48 | 0.750 |
Why?
|
| Aneurysm, Ruptured | 1 | 2021 | 44 | 0.750 |
Why?
|
| Rural Population | 1 | 2023 | 291 | 0.720 |
Why?
|
| Thrombectomy | 1 | 2021 | 169 | 0.680 |
Why?
|
| Spinal Cord | 1 | 2023 | 720 | 0.670 |
Why?
|
| Neoplastic Stem Cells | 4 | 2024 | 1458 | 0.670 |
Why?
|
| Reoperation | 1 | 2024 | 1390 | 0.670 |
Why?
|
| Brain Neoplasms | 5 | 2023 | 4955 | 0.620 |
Why?
|
| Neurosurgeons | 1 | 2017 | 17 | 0.600 |
Why?
|
| Child | 17 | 2024 | 30496 | 0.540 |
Why?
|
| Cell Culture Techniques | 1 | 2019 | 573 | 0.530 |
Why?
|
| Elective Surgical Procedures | 1 | 2017 | 249 | 0.510 |
Why?
|
| Intraoperative Complications | 1 | 2017 | 288 | 0.490 |
Why?
|
| Humans | 46 | 2024 | 270457 | 0.450 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 1046 | 0.440 |
Why?
|
| Coinfection | 2 | 2024 | 199 | 0.400 |
Why?
|
| Radiosurgery | 1 | 2021 | 1383 | 0.400 |
Why?
|
| Salvage Therapy | 2 | 2020 | 2123 | 0.390 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2013 | 261 | 0.380 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2013 | 372 | 0.380 |
Why?
|
| Retrospective Studies | 11 | 2024 | 39751 | 0.360 |
Why?
|
| Internship and Residency | 5 | 2019 | 1442 | 0.340 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2021 | 7784 | 0.340 |
Why?
|
| Cell Differentiation | 2 | 2019 | 4121 | 0.320 |
Why?
|
| Treatment Outcome | 8 | 2024 | 33708 | 0.300 |
Why?
|
| Polycomb Repressive Complex 1 | 2 | 2018 | 85 | 0.300 |
Why?
|
| Stents | 1 | 2013 | 1003 | 0.290 |
Why?
|
| Postoperative Complications | 3 | 2024 | 5672 | 0.290 |
Why?
|
| Vertebral Artery | 2 | 2023 | 33 | 0.270 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2023 | 10384 | 0.260 |
Why?
|
| Cross-Sectional Studies | 5 | 2022 | 4480 | 0.250 |
Why?
|
| Male | 15 | 2024 | 128105 | 0.240 |
Why?
|
| Neuroendoscopy | 1 | 2024 | 35 | 0.230 |
Why?
|
| Nocardia | 1 | 2023 | 14 | 0.230 |
Why?
|
| Nocardia Infections | 1 | 2023 | 36 | 0.220 |
Why?
|
| Female | 14 | 2024 | 148644 | 0.220 |
Why?
|
| Radiography | 2 | 2021 | 1988 | 0.220 |
Why?
|
| Ontario | 1 | 2023 | 98 | 0.210 |
Why?
|
| Infant | 3 | 2024 | 13939 | 0.210 |
Why?
|
| Skull Base | 1 | 2024 | 225 | 0.210 |
Why?
|
| Child, Preschool | 3 | 2024 | 16999 | 0.200 |
Why?
|
| Cerebral Hemorrhage | 1 | 2023 | 189 | 0.200 |
Why?
|
| Spine | 1 | 2023 | 312 | 0.190 |
Why?
|
| Toxoplasmosis | 1 | 2021 | 49 | 0.190 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2023 | 509 | 0.190 |
Why?
|
| Craniocerebral Trauma | 1 | 2022 | 154 | 0.190 |
Why?
|
| Syndrome | 1 | 2024 | 1406 | 0.180 |
Why?
|
| Decompression, Surgical | 1 | 2021 | 148 | 0.180 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 3031 | 0.170 |
Why?
|
| Pituitary Gland | 1 | 2020 | 151 | 0.170 |
Why?
|
| Brain Ischemia | 1 | 2022 | 311 | 0.160 |
Why?
|
| Cell Membrane Permeability | 1 | 2019 | 124 | 0.160 |
Why?
|
| Wnt Proteins | 1 | 2020 | 384 | 0.150 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2019 | 169 | 0.150 |
Why?
|
| Bacterial Infections | 1 | 2021 | 509 | 0.150 |
Why?
|
| Neoplasm, Residual | 1 | 2024 | 1743 | 0.150 |
Why?
|
| Skin | 1 | 2023 | 1270 | 0.150 |
Why?
|
| Mobile Applications | 1 | 2019 | 109 | 0.150 |
Why?
|
| Sella Turcica | 1 | 2017 | 23 | 0.150 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2017 | 76 | 0.140 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 182 | 0.140 |
Why?
|
| Intersectoral Collaboration | 1 | 2017 | 42 | 0.140 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2020 | 686 | 0.140 |
Why?
|
| Databases, Factual | 1 | 2024 | 2234 | 0.140 |
Why?
|
| Adolescent | 4 | 2024 | 32671 | 0.140 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 1017 | 0.140 |
Why?
|
| Small Molecule Libraries | 1 | 2018 | 195 | 0.140 |
Why?
|
| Cerebellar Diseases | 1 | 2017 | 91 | 0.140 |
Why?
|
| Rhabdoid Tumor | 1 | 2017 | 106 | 0.140 |
Why?
|
| Neoplasms | 1 | 2023 | 15905 | 0.130 |
Why?
|
| Career Choice | 1 | 2017 | 210 | 0.130 |
Why?
|
| Surveys and Questionnaires | 2 | 2019 | 5921 | 0.130 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 470 | 0.130 |
Why?
|
| Proteomics | 1 | 2022 | 1425 | 0.120 |
Why?
|
| Multicenter Studies as Topic | 1 | 2017 | 559 | 0.120 |
Why?
|
| Prosthesis Design | 2 | 2018 | 655 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 1582 | 0.120 |
Why?
|
| Teratoma | 1 | 2017 | 248 | 0.120 |
Why?
|
| Stroke | 1 | 2022 | 1061 | 0.120 |
Why?
|
| Meningioma | 1 | 2017 | 308 | 0.110 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2017 | 554 | 0.110 |
Why?
|
| Cerebral Angiography | 1 | 2013 | 148 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 3164 | 0.110 |
Why?
|
| Scotland | 1 | 2012 | 43 | 0.110 |
Why?
|
| Meningeal Neoplasms | 1 | 2017 | 473 | 0.100 |
Why?
|
| Liver Transplantation | 1 | 2021 | 1191 | 0.100 |
Why?
|
| Equipment Failure Analysis | 1 | 2013 | 327 | 0.100 |
Why?
|
| Pain | 1 | 2021 | 1699 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 2647 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2019 | 3045 | 0.100 |
Why?
|
| Mice | 6 | 2024 | 35592 | 0.100 |
Why?
|
| Neurologic Examination | 1 | 2012 | 263 | 0.100 |
Why?
|
| Patient Discharge | 1 | 2017 | 698 | 0.100 |
Why?
|
| Feasibility Studies | 1 | 2017 | 2364 | 0.100 |
Why?
|
| Delayed Diagnosis | 1 | 2012 | 152 | 0.090 |
Why?
|
| Age Distribution | 1 | 2012 | 713 | 0.090 |
Why?
|
| Adult | 4 | 2022 | 81754 | 0.090 |
Why?
|
| Curriculum | 1 | 2017 | 913 | 0.090 |
Why?
|
| Biopsy | 1 | 2018 | 3387 | 0.090 |
Why?
|
| Infant, Newborn | 1 | 2024 | 8626 | 0.090 |
Why?
|
| Biomedical Research | 1 | 2017 | 798 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2023 | 7897 | 0.080 |
Why?
|
| Animals | 6 | 2024 | 62021 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 2618 | 0.080 |
Why?
|
| Hospitalization | 1 | 2017 | 2163 | 0.070 |
Why?
|
| Glioma | 1 | 2018 | 1977 | 0.070 |
Why?
|
| Brain | 4 | 2023 | 4209 | 0.070 |
Why?
|
| Quality of Life | 2 | 2020 | 4773 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2013 | 2854 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2012 | 937 | 0.070 |
Why?
|
| Stem Cells | 2 | 2024 | 1215 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2020 | 13383 | 0.060 |
Why?
|
| Embryonic Structures | 1 | 2024 | 4 | 0.060 |
Why?
|
| Metencephalon | 1 | 2024 | 4 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 5001 | 0.060 |
Why?
|
| Rhombencephalon | 1 | 2024 | 47 | 0.060 |
Why?
|
| Stem Cell Niche | 1 | 2024 | 93 | 0.060 |
Why?
|
| Time Factors | 1 | 2017 | 12991 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2024 | 630 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2023 | 3914 | 0.050 |
Why?
|
| Streptococcus pyogenes | 1 | 2023 | 130 | 0.050 |
Why?
|
| Milrinone | 1 | 2022 | 31 | 0.050 |
Why?
|
| Cerebral Infarction | 1 | 2022 | 72 | 0.050 |
Why?
|
| Cell Proliferation | 3 | 2020 | 7242 | 0.050 |
Why?
|
| Young Adult | 2 | 2017 | 22152 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2023 | 14836 | 0.050 |
Why?
|
| Aspirin | 1 | 2022 | 374 | 0.040 |
Why?
|
| Aged | 2 | 2017 | 73175 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2023 | 7371 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2024 | 1038 | 0.040 |
Why?
|
| Heterografts | 1 | 2020 | 741 | 0.040 |
Why?
|
| Wnt Signaling Pathway | 1 | 2020 | 445 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 30936 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2017 | 190 | 0.040 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2017 | 93 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 717 | 0.040 |
Why?
|
| beta Catenin | 1 | 2020 | 688 | 0.030 |
Why?
|
| Workload | 1 | 2017 | 200 | 0.030 |
Why?
|
| Health Surveys | 1 | 2017 | 400 | 0.030 |
Why?
|
| Prognosis | 1 | 2012 | 22475 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 356 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2020 | 1035 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 9041 | 0.030 |
Why?
|
| Self Report | 1 | 2017 | 797 | 0.030 |
Why?
|
| Skull Base Neoplasms | 1 | 2017 | 339 | 0.030 |
Why?
|
| Middle Aged | 2 | 2017 | 90100 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2018 | 2421 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 3061 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 2299 | 0.030 |
Why?
|
| Chromatin | 1 | 2017 | 1043 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2017 | 3592 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 1443 | 0.020 |
Why?
|
| Leukemia | 1 | 2018 | 1720 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 5142 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2023 | 4960 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2018 | 3555 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 5407 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 15191 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2017 | 12104 | 0.010 |
Why?
|